MR-targeted TRUS prostate biopsy using local reference augmentation: initial experience.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27068817)

Published in Int Urol Nephrol on April 11, 2016

Authors

Wendy J M van de Ven1, Wulphert Venderink2, J P Michiel Sedelaar3, Jeroen Veltman4, Jelle O Barentsz2, Jurgen J Fütterer2, Erik B Cornel5, Henkjan J Huisman2

Author Affiliations

1: Department of Radiology and Nuclear Medicine, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. Wendy.vandeVen@radboudumc.nl.
2: Department of Radiology and Nuclear Medicine, Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.
3: Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
4: Department of Radiology, ZGT, Hengelo, The Netherlands.
5: Department of Urology, ZGT, Hengelo, The Netherlands.

Articles cited by this

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol (2005) 12.31

ESUR prostate MR guidelines 2012. Eur Radiol (2012) 8.86

Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol (2013) 4.64

Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Eur Urol (2014) 4.56

Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol (2011) 3.19

Real time MRI-ultrasound image guided stereotactic prostate biopsy. Magn Reson Imaging (2002) 2.69

Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study. Radiology (2013) 2.47

Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. Eur Urol (2013) 2.43

Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. J Urol (2012) 2.32

Serial biopsy results in prostate cancer screening study. J Urol (2002) 2.30

The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology (1997) 2.29

MR to ultrasound registration for image-guided prostate interventions. Med Image Anal (2010) 2.07

Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care. Eur Urol (2012) 2.05

Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging (2007) 1.90

Prostate cancer detection with 3 T MRI: comparison of diffusion-weighted imaging and dynamic contrast-enhanced MRI in combination with T2-weighted imaging. J Magn Reson Imaging (2010) 1.87

Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJU Int (2007) 1.86

The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance. J Urol (2013) 1.38

Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study. BJU Int (2008) 1.37

Sensitivity and specificity of sextant biopsies in the detection of prostate cancer: preliminary report. Urology (1999) 1.16

Technique for a hybrid system of real-time transrectal ultrasound with preoperative magnetic resonance imaging in the guidance of targeted prostate biopsy. Int J Urol (2010) 0.96

Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years. Urology (2008) 0.96

Simulated required accuracy of image registration tools for targeting high-grade cancer components with prostate biopsies. Eur Radiol (2012) 0.92

Trans-rectal ultrasound visibility of prostate lesions identified by magnetic resonance imaging increases accuracy of image-fusion targeted biopsies. World J Urol (2015) 0.86

Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis. Med Phys (2014) 0.80